BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21069633)

  • 1. Microparticles: key protagonists in cardiovascular disorders.
    Amabile N; Rautou PE; Tedgui A; Boulanger CM
    Semin Thromb Hemost; 2010 Nov; 36(8):907-16. PubMed ID: 21069633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microparticles in cardiovascular disease pathophysiology and outcomes.
    Viera AJ; Mooberry M; Key NS
    J Am Soc Hypertens; 2012; 6(4):243-52. PubMed ID: 22789878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microparticles, vascular function, and atherothrombosis.
    Rautou PE; Vion AC; Amabile N; Chironi G; Simon A; Tedgui A; Boulanger CM
    Circ Res; 2011 Aug; 109(5):593-606. PubMed ID: 21852557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticles, vascular function and hypertension.
    Boulanger CM
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles: targets and tools in cardiovascular disease.
    Martinez MC; Tual-Chalot S; Leonetti D; Andriantsitohaina R
    Trends Pharmacol Sci; 2011 Nov; 32(11):659-65. PubMed ID: 21794929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms underlying the formation of circulating microparticles.
    Morel O; Jesel L; Freyssinet JM; Toti F
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):15-26. PubMed ID: 21160064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, cell differentiation, angiogenesis--microparticles and their roles in angiogenesis.
    Shai E; Varon D
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):10-4. PubMed ID: 21160063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The many faces of endothelial microparticles.
    Dignat-George F; Boulanger CM
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microparticles and procoagulant activity in elderly patients.
    Forest A; Pautas E; Ray P; Bonnet D; Verny M; Amabile N; Boulanger C; Riou B; Tedgui A; Mallat Z; Boddaert J
    J Gerontol A Biol Sci Med Sci; 2010 Apr; 65(4):414-20. PubMed ID: 19942591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?
    Tushuizen ME; Diamant M; Sturk A; Nieuwland R
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):4-9. PubMed ID: 21160062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microparticles and female issues].
    Toth B
    Hamostaseologie; 2009 Jan; 29(1):46-50. PubMed ID: 19151846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microparticles: pathophysiology and clinical implications.
    Piccin A; Murphy WG; Smith OP
    Blood Rev; 2007 May; 21(3):157-71. PubMed ID: 17118501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
    Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
    J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte-derived microparticles in vascular homeostasis.
    Angelillo-Scherrer A
    Circ Res; 2012 Jan; 110(2):356-69. PubMed ID: 22267840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITP.
    Fontana V; Jy W; Ahn ER; Dudkiewicz P; Horstman LL; Duncan R; Ahn YS
    Thromb Res; 2008; 122(5):599-603. PubMed ID: 18334267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
    Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
    Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles and arterial disease.
    Blann A; Shantsila E; Shantsila A
    Semin Thromb Hemost; 2009 Jul; 35(5):488-96. PubMed ID: 19739039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving role of microparticles in the pathophysiology of endothelial dysfunction.
    Lovren F; Verma S
    Clin Chem; 2013 Aug; 59(8):1166-74. PubMed ID: 23529703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microparticles and cardiovascular disease].
    Morel O; Ohlmann P; Morel N; Jesel L; Bareiss P; Freyssinet JM; Toti F
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):226-35. PubMed ID: 15816326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles in cancer.
    Rak J
    Semin Thromb Hemost; 2010 Nov; 36(8):888-906. PubMed ID: 21049390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.